A strong performance in Siemens Healthcare's Imaging & IT division was more than overcome by significant goodwill impairment charges in other Siemens healthcare business units in the fourth quarter.
For the period (end-September 30), the Erlangen, Germany-based division posted revenues of 3.4 billion euros ($4.8 billion U.S.), up 9% on an actual basis and 1% on a currency-adjusted basis from the 3.1 billion euros ($4.7 billion U.S.) reported from the fourth quarter last year.
Thanks to impairment charges of 1.2 billion euros ($1.7 billion U.S.) in its Diagnostics division and 96 million euros ($133.7 million U.S.) in charges in its Workflow & Solutions unit, Siemens Healthcare had a net loss of 772 million euros ($1.1 billion U.S.) in the fourth quarter; a year ago, Siemens had a 2009 fourth quarter with net income of 483 million euros ($672.5 million U.S.).
In quarterly highlights, the Imaging & IT division produced profit of 392 million euros ($545.8 million U.S.), a 10% increase from the fiscal 2009 fourth quarter. Siemens credited the earnings growth in part to higher revenue and a favorable product mix. Double-digit order growth in the Americas also included strong demand in the U.S., Siemens said.
Related Reading
Siemens partners with ScImage, November 15, 2010
Siemens offers PERCIST tool for oncology, November 3, 2010
Siemens celebrates CT milestone, November 2, 2010
Siemens scores $25M Rush contract, October 26, 2010
Siemens targets breast cancer awareness, October 13, 2010
Copyright © 2010 AuntMinnie.com














![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)


